Latest Protease inhibitor Stories
BRISBANE, Calif., Sept. 8 /PRNewswire-FirstCall/ -- InterMune, Inc. today announced that Steven B. Porter, M.D., Ph.D., Chief Medical Officer of InterMune, will present at the Robert W. Baird & Co. Small Cap Healthcare Conference in New York on September 10, 2008 at 10:30 a.m. EDT.
BRISBANE, Calif., Sept. 2 /PRNewswire-FirstCall/ -- InterMune, Inc.
BRISBANE, Calif., Aug. 29 /PRNewswire-FirstCall/ -- InterMune, Inc. today announced that Daniel G. Welch, Chairman, CEO and President of InterMune, will present at the Thomas Weisel Partners Healthcare Conference in Boston on September 4, 2008 at 10:55 a.m. EDT.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the Company has reached agreement with U.S. and E.U.
BRISBANE, Calif., July 30 /PRNewswire-FirstCall/ -- InterMune, Inc. today announced that Daniel G. Welch, Chairman, CEO and President of InterMune, will present at the BMO Capital Markets 2008 Focus on Healthcare Conference in New York on August 6, 2008 at 10:00 a.m. EDT.
CAMBRIDGE, Mass., July 29 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced the appointment of Freda C. Lewis-Hall, M.D. as Executive Vice President, Medicines Development. Dr.
NanoViricides, Inc. (OTC BB: NNVC.OB), (the "Company") said that its lead anti-HIV drug candidate demonstrated markedly superior survival results in the test animals when compared to those animals given the anti-HIV "combo cocktail" in a double-blind animal study.
The combined supercomputing power of the UK and US â€˜national gridsâ€™ has enabled UCL (University College London) scientists to simulate the efficacy of an HIV drug in blocking a key protein used by the lethal virus. The method â€“ an early example of the Virtual Physiological Human in action â€“ could one day be used to tailor personal drug treatments, for example for HIV patients developing resistance to their drugs.
By Maggie Fox, Health and Science Correspondent TORONTO (Reuters) - Simpler drug combinations can control the AIDS virus well, researchers said on Sunday in several reports that will help in trying to mix and match nearly two dozen different HIV drugs in lifesaving cocktails.